CDT Equity, Inc. (CDT)
0.91
-0.08
(-8.08%)
USD |
NASDAQ |
Oct 05, 16:00
0.99
+0.08
(+8.79%)
After-Hours: 20:00
CDT Equity Total Assets (Quarterly) : 126.71M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 126.71M |
| March 31, 2026 | 127.09M |
| December 31, 2025 | 5.65M |
| September 30, 2025 | 8.552M |
| June 30, 2025 | 7.989M |
| March 31, 2025 | 7.714M |
| December 31, 2024 | 4.193M |
| September 30, 2024 | 2.993M |
| June 30, 2024 | 3.305M |
| March 31, 2024 | 4.917M |
| Date | Value |
|---|---|
| December 31, 2023 | 7.224M |
| September 30, 2023 | 12.02M |
| June 30, 2023 | 23.69M |
| March 31, 2023 | 23.97M |
| December 31, 2022 | 0.005M |
| September 30, 2022 | 136.85M |
| June 30, 2022 | 136.47M |
| March 31, 2022 | 136.53M |
| December 31, 2021 | 0.2131M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Windtree Therapeutics, Inc. | 15.98M |
| Lifecore Biomedical, Inc. | 229.50M |
| Codexis, Inc. | 120.06M |
| Navidea Biopharmaceuticals, Inc. | -- |
| Biostax Corp. | -- |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 23.62M |
| Shareholders Equity (Quarterly) | 103.09M |
| Debt to Equity Ratio | 0.0115 |
| Current Ratio | 0.1258 |
| Net Debt Paydown Yield | 9.55% |